Looking at Enanta Pharmaceuticals, Inc.'s (NASDAQ:ENTA ) insider transactions over the last year, we can see that insiders were net buyers. That is, there were more number of shares purchased by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback